Select publications
Andre T et al; Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350(23):2343-51. Abstract
Barrier A et al. Stage II colon cancer prognosis prediction by tumor gene expression profiling. J Clin Oncol 2006;24(29):4685-91. Abstract
Benson AB 3rd et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 2004;22(16):3408-19. Abstract
Chung KY, Kelsen D. Adjuvant therapy for stage II colorectal cancer: Who and with what? Curr Treat Options Gastroenterol 2006;9(3):272-80. Abstract
Cronin DP et al. Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer. Am J Gastroenterol 2006;101(10):2308-18. Abstract
De Gramont A et al. Oxaliplatin/5FU/LV in the adjuvant treatment of stage II and stage III colon cancer: Efficacy results with a median follow-up of 4 years. Proc ASCO 2005;Abstract 3501.
Figueredo A et al. Adjuvant therapy for stage II colon cancer: A systematic review from the Cancer Care Ontario Program in Evidence-Based Care’s gastrointestinal cancer disease site group. J Clin Oncol 2004;22(16):3395-407. Abstract
Funaioli C et al. Does biomolecular characterization of stage II/III colorectal cancer have any prognostic value? Clin Colorectal Cancer 2006;6(1):38-45. Abstract
Gill S et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: Who benefits and by how much? J Clin Oncol 2004;22(10):1797-806. Abstract
Gray RG et al. QUASAR: A randomized study of adjuvant chemotherapy (CT) vs observation including 3238 colorectal cancer patients. Proc ASCO 2004;Abstract 3501.
Hickish T et al. Stage II patients in the “MOSAIC” trial evaluating oxaliplatin/5-FU/LV as adjuvant treatment of colon cancer: A subpopulation analysis. Ann Oncol 2004;15(Suppl 3):III76;Abstract 284P.
Love N et al. How well do we communicate with our patients? A survey of patients who received adjuvant chemotherapy for colorectal cancer. Gastrointestinal Cancers Symposium 2007;Abstract 239.
Lanza G et al. Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients. J Clin Oncol 2006;24(15):2359-67. Abstract
Morris M et al. Survival rates for stage II colon cancer patients treated with or without chemotherapy in a population-based setting. Int J Colorectal Dis 2007;[Epub ahead of print]. Abstract
